HCWB Return on Tangible Equity | HCW Biologics Inc.

HCW Biologics Inc. (HCWB) Return on Tangible Equity

2026-06-30: Return Tang Equity -75.15%.
2026-03-31: Return Tang Equity -39.75%.
2025-12-31: Return Tang Equity -287.90%.
2025-09-30: Return Tang Equity 571.95%.

Complete source-backed return tang equity history.

Available history: 2020-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-75.15%
2026-03-31	-39.75%
2025-12-31	-287.90%
2025-09-30	571.95%
2025-06-30	21935.21%
2025-03-31	289.10%
2024-12-31	443.47%
2024-09-30	374.45%
2024-06-30	609.03%
2024-03-31	-313.38%
2023-12-31	-185.67%
2023-09-30	-82.68%
2023-06-30	-65.45%
2023-03-31	-54.92%
2022-12-31	-39.81%
2022-09-30	-29.74%
2022-06-30	-27.80%
2022-03-31	-24.45%
2021-12-31	-25.13%
2021-09-30	-14.12%
2021-06-30	26.86%
2021-03-31	31.31%
2020-12-31	34.71%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-287.90%
2024-12-31	443.47%
2023-12-31	-185.67%
2022-12-31	-39.81%
2021-12-31	-25.13%
2020-12-31	34.71%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
REVELATION BIOSCIENCES, INC. (REVB)	United States	$0.004B
Onconetix, Inc. (ONCO)	United States	$0.004B
Aptevo Therapeutics Inc. (APVO)	United States	$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)	United States	$0.004B	-0.59
Sunshine Biopharma Inc. (SBFM)		$0.003B
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Alaunos Therapeutics, Inc. (TCRT)	United States	$0.003B	-1.44
Genprex, Inc. (GNPX)	United States	$0.003B	-0.02
Silo Pharma, Inc. (SILO)	United States	$0.003B	-1.57